Probius
PrivateLast Round
Debt
Aug 26, 2025
Total Funding Raised
$20.93M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Probius is a biotechnology research company developing a deep-tech platform that combines quantum sensing and artificial intelligence for biochemical analysis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery, Sensors, Medical AI
Business Model
B2B
Customer Profile
Hardware + Subscription, Subscription SaaS, Usage-Based SaaS, Hardware Sales, Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Probius Comparables
Compare Probius with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nautilus Biotechnology | 73% | |
| Seer | 70% | |
| Quantum-Si | 68% |
Probius Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Aug 26, 2025 | ||||
| Series A | Oct 19, 2022 | ||||
| Grant | Jun 15, 2020 | ||||
| Seed | Dec 3, 2018 |
Probius Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cota Capital | Series A |
| StartX | Seed |
| Baidu Ventures | Series A |
| TSV Capital | Seed |
| Joyance Partners | Seed |
| Defense Advanced Research Projects Agency | Grant |
| Shanda Group | Seed, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 197% MoM, reaching 1.6K.
- Jul 25, 2026
Monthly visitors grew 181% MoM, reaching 543.
Recent news
Latest coverage and updates
- is_developingSep 18, 2026
Probius is developing AI-enabled approach to TB screening on Sep 18th '26.
- is_developingSep 18, 2026
Probius is developing tools for biomedical analysis and diagnostics.
Probius Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Probius's valuation, stock price, and market status.
Is Probius a public or private company?
Probius is a private company.
What is the current stock price of Probius?
Probius is a private company with no public stock price. No recent secondary market data is available.
How much is Probius worth (valuation)?
Valuation information for Probius is not publicly available.
Can I buy Probius stock?
Probius shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Probius's last funding round?
Probius's most recent funding round was Debt on August 26, 2025.
Who are the main investors in Probius?
Key investors in Probius include Cota Capital.
Will Probius IPO soon?
No public IPO plans have been announced for Probius.
How can I track Probius secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Probius's secondary market activity and sign up for updates.